ArticleF&S reports2023
Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis.
Juan C Arjona Ferreira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papertrialcites it